| Symbol |
Name |
|
ABCA4
|
ATP-binding cassette, sub-family A (ABC1), member 4
|
|
ABCB1
|
ATP-binding cassette, sub-family B (MDR/TAP), member 1
|
|
ABCC1
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 1
|
|
ABCC2
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 2
|
|
ABCC8
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 8
|
|
ABCG8
|
ATP-binding cassette, sub-family G (WHITE), member 8
|
|
ABL1
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
|
ACAN
|
aggrecan
|
|
ACE
|
angiotensin I converting enzyme
|
|
ACKR1
|
atypical chemokine receptor 1 (Duffy blood group)
|
|
ADA
|
adenosine deaminase
|
|
ADIPOQ
|
adiponectin, C1Q and collagen domain containing
|
|
ADM
|
adrenomedullin
|
|
ADRA2B
|
adrenoceptor alpha 2B
|
|
ADRB2
|
adrenoceptor beta 2, surface
|
|
ADRB3
|
adrenoceptor beta 3
|
|
AGER
|
advanced glycosylation end product-specific receptor
|
|
ALDH5A1
|
aldehyde dehydrogenase 5 family, member A1
|
|
AMH
|
anti-Mullerian hormone
|
|
APBB1
|
amyloid beta (A4) precursor protein-binding, family B, member 1 (Fe65)
|
|
APC
|
adenomatous polyposis coli
|
|
APOA1
|
apolipoprotein A-I
|
|
APOB
|
apolipoprotein B
|
|
APOE
|
apolipoprotein E
|
|
APP
|
amyloid beta (A4) precursor protein
|
|
AQP4
|
aquaporin 4
|
|
AR
|
androgen receptor
|
|
ARX
|
aristaless related homeobox
|
|
AS3MT
|
arsenite methyltransferase
|
|
ASPM
|
asp (abnormal spindle) homolog, microcephaly associated (Drosophila)
|
|
ATG7
|
autophagy related 7
|
|
ATP1A3
|
ATPase, Na+/K+ transporting, alpha 3 polypeptide
|
|
ATXN2
|
ataxin 2
|
|
AVEN
|
apoptosis, caspase activation inhibitor
|
|
B2M
|
beta-2-microglobulin
|
|
BAP1
|
BRCA1 associated protein-1 (ubiquitin carboxy-terminal hydrolase)
|
|
BCHE
|
butyrylcholinesterase
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BCR
|
breakpoint cluster region
|
|
BDNF
|
brain-derived neurotrophic factor
|
|
BEST1
|
bestrophin 1
|
|
BMPR1B
|
bone morphogenetic protein receptor, type IB
|
|
BMPR2
|
bone morphogenetic protein receptor, type II (serine/threonine kinase)
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
|
BRCA1
|
breast cancer 1, early onset
|
|
BRCA2
|
breast cancer 2, early onset
|
|
BST2
|
bone marrow stromal cell antigen 2
|
|
C3
|
complement component 3
|
|
CANT1
|
calcium activated nucleotidase 1
|
|
CAT
|
catalase
|
|
CAV3
|
caveolin 3
|
|
CBS
|
cystathionine-beta-synthase
|
|
CCL17
|
chemokine (C-C motif) ligand 17
|
|
CCL22
|
chemokine (C-C motif) ligand 22
|
|
CCL27
|
chemokine (C-C motif) ligand 27
|
|
CCL5
|
chemokine (C-C motif) ligand 5
|
|
CCND1
|
cyclin D1
|
|
CCR2
|
chemokine (C-C motif) receptor 2
|
|
CD1B
|
CD1b molecule
|
|
CD226
|
CD226 molecule
|
|
CD24
|
CD24 molecule
|
|
CD44
|
CD44 molecule (Indian blood group)
|
|
CDC20
|
cell division cycle 20
|
|
CDH2
|
cadherin 2, type 1, N-cadherin (neuronal)
|
|
CDK5
|
cyclin-dependent kinase 5
|
|
CDKAL1
|
CDK5 regulatory subunit associated protein 1-like 1
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
|
CDX2
|
caudal type homeobox 2
|
|
CETP
|
cholesteryl ester transfer protein, plasma
|
|
CFTR
|
cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)
|
|
CGA
|
glycoprotein hormones, alpha polypeptide
|
|
CHEK2
|
checkpoint kinase 2
|
|
CHGA
|
chromogranin A
|
|
CHGB
|
chromogranin B
|
|
CHI3L1
|
chitinase 3-like 1 (cartilage glycoprotein-39)
|
|
CHIT1
|
chitinase 1 (chitotriosidase)
|
|
CHM
|
choroideremia (Rab escort protein 1)
|
|
CHMP2B
|
charged multivesicular body protein 2B
|
|
CHRNA4
|
cholinergic receptor, nicotinic, alpha 4 (neuronal)
|
|
CHRNA5
|
cholinergic receptor, nicotinic, alpha 5 (neuronal)
|
|
CKB
|
creatine kinase, brain
|
|
CLN8
|
ceroid-lipofuscinosis, neuronal 8 (epilepsy, progressive with mental retardation)
|
|
CLU
|
clusterin
|
|
CMAHP
|
cytidine monophospho-N-acetylneuraminic acid hydroxylase, pseudogene
|
|
CNR1
|
cannabinoid receptor 1 (brain)
|
|
CNR2
|
cannabinoid receptor 2 (macrophage)
|
|
COL1A1
|
collagen, type I, alpha 1
|
|
COL4A1
|
collagen, type IV, alpha 1
|
|
COMP
|
cartilage oligomeric matrix protein
|
|
COMT
|
catechol-O-methyltransferase
|
|
CPA4
|
carboxypeptidase A4
|
|
CPB2
|
carboxypeptidase B2 (plasma)
|
|
CPLX2
|
complexin 2
|
|
CPT1A
|
carnitine palmitoyltransferase 1A (liver)
|
|
CRP
|
C-reactive protein, pentraxin-related
|
|
CRYGS
|
crystallin, gamma S
|
|
CST3
|
cystatin C
|
|
CTGF
|
connective tissue growth factor
|
|
CTLA4
|
cytotoxic T-lymphocyte-associated protein 4
|
|
CX3CR1
|
chemokine (C-X3-C motif) receptor 1
|
|
CXCL10
|
chemokine (C-X-C motif) ligand 10
|
|
CXCL12
|
chemokine (C-X-C motif) ligand 12
|
|
CXCL13
|
chemokine (C-X-C motif) ligand 13
|
|
CXCL9
|
chemokine (C-X-C motif) ligand 9
|
|
CYBA
|
cytochrome b-245, alpha polypeptide
|
|
CYP11A1
|
cytochrome P450, family 11, subfamily A, polypeptide 1
|
|
CYP1A1
|
cytochrome P450, family 1, subfamily A, polypeptide 1
|
|
CYP1B1
|
cytochrome P450, family 1, subfamily B, polypeptide 1
|
|
CYP2A6
|
cytochrome P450, family 2, subfamily A, polypeptide 6
|
|
CYP2B6
|
cytochrome P450, family 2, subfamily B, polypeptide 6
|
|
CYP2D6
|
cytochrome P450, family 2, subfamily D, polypeptide 6
|
|
CYP2E1
|
cytochrome P450, family 2, subfamily E, polypeptide 1
|
|
CYP3A4
|
cytochrome P450, family 3, subfamily A, polypeptide 4
|
|
CYP3A5
|
cytochrome P450, family 3, subfamily A, polypeptide 5
|
|
DEFB4A
|
defensin, beta 4A
|
|
DICER1
|
dicer 1, ribonuclease type III
|
|
DLEC1
|
deleted in lung and esophageal cancer 1
|
|
DMPK
|
dystrophia myotonica-protein kinase
|
|
DNM2
|
dynamin 2
|
|
DOK7
|
docking protein 7
|
|
DRD2
|
dopamine receptor D2
|
|
DRD4
|
dopamine receptor D4
|
|
DTNBP1
|
dystrobrevin binding protein 1
|
|
ECE1
|
endothelin converting enzyme 1
|
|
EGFR
|
epidermal growth factor receptor
|
|
EIF5A2
|
eukaryotic translation initiation factor 5A2
|
|
ENPP1
|
ectonucleotide pyrophosphatase/phosphodiesterase 1
|
|
EPO
|
erythropoietin
|
|
ERAP1
|
endoplasmic reticulum aminopeptidase 1
|
|
ERAP2
|
endoplasmic reticulum aminopeptidase 2
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
ERCC1
|
excision repair cross-complementation group 1
|
|
ERCC2
|
excision repair cross-complementation group 2
|
|
ESR1
|
estrogen receptor 1
|
|
ETS1
|
v-ets avian erythroblastosis virus E26 oncogene homolog 1
|
|
ETV6
|
ets variant 6
|
|
EZR
|
ezrin
|
|
F11
|
coagulation factor XI
|
|
F12
|
coagulation factor XII (Hageman factor)
|
|
F2
|
coagulation factor II (thrombin)
|
|
F5
|
coagulation factor V (proaccelerin, labile factor)
|
|
F7
|
coagulation factor VII (serum prothrombin conversion accelerator)
|
|
F9
|
coagulation factor IX
|
|
FADS1
|
fatty acid desaturase 1
|
|
FADS2
|
fatty acid desaturase 2
|
|
FASLG
|
Fas ligand (TNF superfamily, member 6)
|
|
FBLN5
|
fibulin 5
|
|
FCGR3A
|
Fc fragment of IgG, low affinity IIIa, receptor (CD16a)
|
|
FEN1
|
flap structure-specific endonuclease 1
|
|
FGB
|
fibrinogen beta chain
|
|
FGF21
|
fibroblast growth factor 21
|
|
FGF23
|
fibroblast growth factor 23
|
|
FLG
|
filaggrin
|
|
FLT3
|
fms-related tyrosine kinase 3
|
|
FMR1
|
fragile X mental retardation 1
|
|
FOLR1
|
folate receptor 1 (adult)
|
|
FSHR
|
follicle stimulating hormone receptor
|
|
FTO
|
fat mass and obesity associated
|
|
FXN
|
frataxin
|
|
G6PD
|
glucose-6-phosphate dehydrogenase
|
|
GATA1
|
GATA binding protein 1 (globin transcription factor 1)
|
|
GCG
|
glucagon
|
|
GCH1
|
GTP cyclohydrolase 1
|
|
GCK
|
glucokinase (hexokinase 4)
|
|
GFAP
|
glial fibrillary acidic protein
|
|
GHR
|
growth hormone receptor
|
|
GHSR
|
growth hormone secretagogue receptor
|
|
GIP
|
gastric inhibitory polypeptide
|
|
GJB2
|
gap junction protein, beta 2, 26kDa
|
|
GLA
|
galactosidase, alpha
|
|
GLUD1
|
glutamate dehydrogenase 1
|
|
GLUD2
|
glutamate dehydrogenase 2
|
|
GNB3
|
guanine nucleotide binding protein (G protein), beta polypeptide 3
|
|
GP1BA
|
glycoprotein Ib (platelet), alpha polypeptide
|
|
GPT
|
glutamic-pyruvate transaminase (alanine aminotransferase)
|
|
GSTM1
|
glutathione S-transferase mu 1
|
|
GSTO2
|
glutathione S-transferase omega 2
|
|
GSTP1
|
glutathione S-transferase pi 1
|
|
GSTT1
|
glutathione S-transferase theta 1
|
|
GUCA1A
|
guanylate cyclase activator 1A (retina)
|
|
HBA1
|
hemoglobin, alpha 1
|
|
HDAC2
|
histone deacetylase 2
|
|
HDAC3
|
histone deacetylase 3
|
|
HDAC5
|
histone deacetylase 5
|
|
HGD
|
homogentisate 1,2-dioxygenase
|
|
HGF
|
hepatocyte growth factor (hepapoietin A; scatter factor)
|
|
HHEX
|
hematopoietically expressed homeobox
|
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
|
HLA-B
|
major histocompatibility complex, class I, B
|
|
HLA-C
|
major histocompatibility complex, class I, C
|
|
HLA-DPB1
|
major histocompatibility complex, class II, DP beta 1
|
|
HLA-DQA1
|
major histocompatibility complex, class II, DQ alpha 1
|
|
HLA-DQB1
|
major histocompatibility complex, class II, DQ beta 1
|
|
HLA-DRB1
|
major histocompatibility complex, class II, DR beta 1
|
|
HLA-F
|
major histocompatibility complex, class I, F
|
|
HLA-G
|
major histocompatibility complex, class I, G
|
|
HMOX1
|
heme oxygenase 1
|
|
HNF1A
|
HNF1 homeobox A
|
|
HNF1B
|
HNF1 homeobox B
|
|
HNF4A
|
hepatocyte nuclear factor 4, alpha
|
|
HRAS
|
Harvey rat sarcoma viral oncogene homolog
|
|
HSD11B1
|
hydroxysteroid (11-beta) dehydrogenase 1
|
|
HTT
|
huntingtin
|
|
ICAM1
|
intercellular adhesion molecule 1
|
|
ID1
|
inhibitor of DNA binding 1, dominant negative helix-loop-helix protein
|
|
IDH1
|
isocitrate dehydrogenase 1 (NADP+), soluble
|
|
IDS
|
iduronate 2-sulfatase
|
|
IFNG
|
interferon, gamma
|
|
IFNL3
|
interferon, lambda 3
|
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
|
IGH
|
immunoglobulin heavy locus
|
|
IL10
|
interleukin 10
|
|
IL10RA
|
interleukin 10 receptor, alpha
|
|
IL10RB
|
interleukin 10 receptor, beta
|
|
IL12A
|
interleukin 12A
|
|
IL12B
|
interleukin 12B
|
|
IL13
|
interleukin 13
|
|
IL15RA
|
interleukin 15 receptor, alpha
|
|
IL18
|
interleukin 18
|
|
IL1A
|
interleukin 1, alpha
|
|
IL1B
|
interleukin 1, beta
|
|
IL1RN
|
interleukin 1 receptor antagonist
|
|
IL2
|
interleukin 2
|
|
IL23A
|
interleukin 23, alpha subunit p19
|
|
IL5
|
interleukin 5
|
|
IL6
|
interleukin 6
|
|
IL6R
|
interleukin 6 receptor
|
|
IL7
|
interleukin 7
|
|
INS
|
insulin
|
|
INVS
|
inversin
|
|
ITGA2B
|
integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41)
|
|
ITGB3
|
integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61)
|
|
JAK2
|
Janus kinase 2
|
|
KCNH2
|
potassium channel, voltage gated eag related subfamily H, member 2
|
|
KCNJ11
|
potassium channel, inwardly rectifying subfamily J, member 11
|
|
KCNQ1
|
potassium channel, voltage gated KQT-like subfamily Q, member 1
|
|
KDR
|
kinase insert domain receptor
|
|
KIT
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
|
|
KL
|
klotho
|
|
KLK3
|
kallikrein-related peptidase 3
|
|
KMT2A
|
lysine (K)-specific methyltransferase 2A
|
|
KRAS
|
Kirsten rat sarcoma viral oncogene homolog
|
|
LACRT
|
lacritin
|
|
LCN2
|
lipocalin 2
|
|
LCT
|
lactase
|
|
LEP
|
leptin
|
|
LHCGR
|
luteinizing hormone/choriogonadotropin receptor
|
|
LPL
|
lipoprotein lipase
|
|
LRRK2
|
leucine-rich repeat kinase 2
|
|
LTBP2
|
latent transforming growth factor beta binding protein 2
|
|
MAPKAPK2
|
mitogen-activated protein kinase-activated protein kinase 2
|
|
MAPT
|
microtubule-associated protein tau
|
|
MBL2
|
mannose-binding lectin (protein C) 2, soluble
|
|
MC4R
|
melanocortin 4 receptor
|
|
MCPH1
|
microcephalin 1
|
|
MDM2
|
MDM2 proto-oncogene, E3 ubiquitin protein ligase
|
|
MECOM
|
MDS1 and EVI1 complex locus
|
|
MECP2
|
methyl CpG binding protein 2
|
|
MICA
|
MHC class I polypeptide-related sequence A
|
|
MIF
|
macrophage migration inhibitory factor (glycosylation-inhibiting factor)
|
|
MIR196A2
|
microRNA 196a-2
|
|
MKI67
|
marker of proliferation Ki-67
|
|
MLH1
|
mutL homolog 1
|
|
MMP1
|
matrix metallopeptidase 1
|
|
MMP3
|
matrix metallopeptidase 3
|
|
MMP9
|
matrix metallopeptidase 9
|
|
MPO
|
myeloperoxidase
|
|
MS4A1
|
membrane-spanning 4-domains, subfamily A, member 1
|
|
MSH2
|
mutS homolog 2
|
|
MSTN
|
myostatin
|
|
MTHFR
|
methylenetetrahydrofolate reductase (NAD(P)H)
|
|
MUC16
|
mucin 16, cell surface associated
|
|
MUTYH
|
mutY homolog
|
|
MYBPC3
|
myosin binding protein C, cardiac
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
|
MYO7A
|
myosin VIIA
|
|
MYOG
|
myogenin (myogenic factor 4)
|
|
NCAM1
|
neural cell adhesion molecule 1
|
|
NCOA3
|
nuclear receptor coactivator 3
|
|
NELFE
|
negative elongation factor complex member E
|
|
NF1
|
neurofibromin 1
|
|
NFKBIA
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha
|
|
NGFR
|
nerve growth factor receptor
|
|
NLRP3
|
NLR family, pyrin domain containing 3
|
|
NME1
|
NME/NM23 nucleoside diphosphate kinase 1
|
|
NME2
|
NME/NM23 nucleoside diphosphate kinase 2
|
|
NOD1
|
nucleotide-binding oligomerization domain containing 1
|
|
NOD2
|
nucleotide-binding oligomerization domain containing 2
|
|
NOS3
|
nitric oxide synthase 3 (endothelial cell)
|
|
NPC1
|
Niemann-Pick disease, type C1
|
|
NPHP3
|
nephronophthisis 3 (adolescent)
|
|
NPPA
|
natriuretic peptide A
|
|
NPPB
|
natriuretic peptide B
|
|
NPY
|
neuropeptide Y
|
|
NR3C1
|
nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)
|
|
NR4A2
|
nuclear receptor subfamily 4, group A, member 2
|
|
NRG1
|
neuregulin 1
|
|
NRL
|
neural retina leucine zipper
|
|
NTRK2
|
neurotrophic tyrosine kinase, receptor, type 2
|
|
NUMB
|
numb homolog (Drosophila)
|
|
OGG1
|
8-oxoguanine DNA glycosylase
|
|
OPRM1
|
opioid receptor, mu 1
|
|
PABPN1
|
poly(A) binding protein, nuclear 1
|
|
PAEP
|
progestagen-associated endometrial protein
|
|
PARK2
|
parkin RBR E3 ubiquitin protein ligase
|
|
PARK7
|
parkinson protein 7
|
|
PARP1
|
poly (ADP-ribose) polymerase 1
|
|
PBRM1
|
polybromo 1
|
|
PDE4D
|
phosphodiesterase 4D, cAMP-specific
|
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
|
PITX2
|
paired-like homeodomain 2
|
|
PKD1
|
polycystic kidney disease 1 (autosomal dominant)
|
|
PKD2
|
polycystic kidney disease 2 (autosomal dominant)
|
|
PLA2G7
|
phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma)
|
|
POLG
|
polymerase (DNA directed), gamma
|
|
PON1
|
paraoxonase 1
|
|
PPARG
|
peroxisome proliferator-activated receptor gamma
|
|
PRDM16
|
PR domain containing 16
|
|
PRDX2
|
peroxiredoxin 2
|
|
PRKAR1A
|
protein kinase, cAMP-dependent, regulatory, type I, alpha
|
|
PRNP
|
prion protein
|
|
PROC
|
protein C (inactivator of coagulation factors Va and VIIIa)
|
|
PROS1
|
protein S (alpha)
|
|
PRPH2
|
peripherin 2 (retinal degeneration, slow)
|
|
PSEN1
|
presenilin 1
|
|
PSMD9
|
proteasome (prosome, macropain) 26S subunit, non-ATPase, 9
|
|
PTGDS
|
prostaglandin D2 synthase 21kDa (brain)
|
|
PTH
|
parathyroid hormone
|
|
PTTG1
|
pituitary tumor-transforming 1
|
|
RBP4
|
retinol binding protein 4, plasma
|
|
REN
|
renin
|
|
RET
|
ret proto-oncogene
|
|
RGS4
|
regulator of G-protein signaling 4
|
|
RNASE2
|
ribonuclease, RNase A family, 2 (liver, eosinophil-derived neurotoxin)
|
|
RUNX1
|
runt-related transcription factor 1
|
|
S100B
|
S100 calcium binding protein B
|
|
SCARB1
|
scavenger receptor class B, member 1
|
|
SCN5A
|
sodium channel, voltage gated, type V alpha subunit
|
|
SDHB
|
succinate dehydrogenase complex, subunit B, iron sulfur (Ip)
|
|
SELL
|
selectin L
|
|
SERPINA1
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1
|
|
SERPINE1
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1
|
|
SIRT1
|
sirtuin 1
|
|
SLC6A3
|
solute carrier family 6 (neurotransmitter transporter), member 3
|
|
SLC6A4
|
solute carrier family 6 (neurotransmitter transporter), member 4
|
|
SLC8A1
|
solute carrier family 8 (sodium/calcium exchanger), member 1
|
|
SMARCAL1
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a-like 1
|
|
SNCA
|
synuclein, alpha (non A4 component of amyloid precursor)
|
|
SOD1
|
superoxide dismutase 1, soluble
|
|
SOD2
|
superoxide dismutase 2, mitochondrial
|
|
SOX9
|
SRY (sex determining region Y)-box 9
|
|
SPARC
|
secreted protein, acidic, cysteine-rich (osteonectin)
|
|
SPP1
|
secreted phosphoprotein 1
|
|
SREBF1
|
sterol regulatory element binding transcription factor 1
|
|
STK11
|
serine/threonine kinase 11
|
|
SUFU
|
suppressor of fused homolog (Drosophila)
|
|
TERC
|
telomerase RNA component
|
|
TET2
|
tet methylcytosine dioxygenase 2
|
|
TF
|
transferrin
|
|
TFF1
|
trefoil factor 1
|
|
TG
|
thyroglobulin
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
THBD
|
thrombomodulin
|
|
TIMP1
|
TIMP metallopeptidase inhibitor 1
|
|
TIMP2
|
TIMP metallopeptidase inhibitor 2
|
|
TK2
|
thymidine kinase 2, mitochondrial
|
|
TLR1
|
toll-like receptor 1
|
|
TLR2
|
toll-like receptor 2
|
|
TLR3
|
toll-like receptor 3
|
|
TLR4
|
toll-like receptor 4
|
|
TLR6
|
toll-like receptor 6
|
|
TNC
|
tenascin C
|
|
TNF
|
tumor necrosis factor
|
|
TNFRSF8
|
tumor necrosis factor receptor superfamily, member 8
|
|
TOX3
|
TOX high mobility group box family member 3
|
|
TP53
|
tumor protein p53
|
|
TP63
|
tumor protein p63
|
|
TP73
|
tumor protein p73
|
|
TPH2
|
tryptophan hydroxylase 2
|
|
TRG
|
T cell receptor gamma locus
|
|
TRMT2A
|
tRNA methyltransferase 2 homolog A (S. cerevisiae)
|
|
TRPC4AP
|
transient receptor potential cation channel, subfamily C, member 4 associated protein
|
|
TSHB
|
thyroid stimulating hormone, beta
|
|
TSLP
|
thymic stromal lymphopoietin
|
|
TSPO
|
translocator protein (18kDa)
|
|
TTR
|
transthyretin
|
|
UCHL1
|
ubiquitin carboxyl-terminal esterase L1 (ubiquitin thiolesterase)
|
|
UGT1A4
|
UDP glucuronosyltransferase 1 family, polypeptide A4
|
|
USP24
|
ubiquitin specific peptidase 24
|
|
USP40
|
ubiquitin specific peptidase 40
|
|
VCAM1
|
vascular cell adhesion molecule 1
|
|
VCP
|
valosin containing protein
|
|
VDR
|
vitamin D (1,25- dihydroxyvitamin D3) receptor
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
VHL
|
von Hippel-Lindau tumor suppressor, E3 ubiquitin protein ligase
|
|
VIP
|
vasoactive intestinal peptide
|
|
VKORC1
|
vitamin K epoxide reductase complex, subunit 1
|
|
VPS13B
|
vacuolar protein sorting 13 homolog B (yeast)
|
|
VWF
|
von Willebrand factor
|
|
WFDC2
|
WAP four-disulfide core domain 2
|
|
WFS1
|
Wolfram syndrome 1 (wolframin)
|
|
WNT16
|
wingless-type MMTV integration site family, member 16
|
|
WT1
|
Wilms tumor 1
|
|
WWC1
|
WW and C2 domain containing 1
|
|
XPC
|
xeroderma pigmentosum, complementation group C
|
|
XPO1
|
exportin 1
|
|
XRCC1
|
X-ray repair complementing defective repair in Chinese hamster cells 1
|
